SlideShare a Scribd company logo
Thad Yousey
968 Poplar Ridge Road  Aurora, NY 13026  (315) 525-9251  tyousey@yahoo.com
SENIOR DISCOVERY SCIENTIST
Experienced Pharmaceutical Research and Assay Development
Over twelve years of experience thoroughly researching, developing, validating and documenting assays
for GLP pharmacokinetic and pharmacodynamic clinical studies focusing on precision, accuracy, high
throughput and streamlined assay reproducibility of Phase 0-4 analytes of interest. Developing and
validating assays for preclinical experimental compounds and pro drugs. Developing and generating
methods, validations and all documentation in support of cGMP methods with strict adherence to FDA
and ICH guidelines. Performing validation confirmations of cGMP assays to support production line
quality control methods.
Experience
QUINTILES -- Ithaca, NY
Senior Discovery Scientist, 07/11/2007 to 04/19/2015
Eight years developing bioanalytical GLP and non GLP methods for analyte extraction from biological
matrices utilizing LC/MS/MS detection. These methods were ultimately used for the generation of
pharmacokinetic data by some of the world’s largest pharmaceutical providers to support; data in client
drug discovery, maximizing accuracy of Cmax and AUC values for future clinical study drug delivery,
substantiate NDA submissions and/or provide data sets for currently marketed compounds (FDA
requirements). Basic duties included:
• Structural confirmations of analytes, precursors, adducts (if present), ion polarity(ies) functionality
and product ions - utilizing LC/MS/MS (turbo ion spray and heated nebulizer)
• Developing and optimizing mass spectrometric methods and parameters in tandem with HPLC
• Developing and optimizing HPLC methods (reversed, normal phase, HLIC, ion pairing) and
parameters assessing; resolution, capacity factor, peak selectivity, highest throughput, API and or
APCI compatibility and client timeline/demands
• Developing/validating chiral and isomeric selective HPLC assays including confirmation of all
chromatographically resolved species
• Researching, developing and validating methods of extraction for analytes, metabolites internal
standards (analogue and stable labeled) and/or pro-drugs from biological matrices to be utilized in
LC/MS/MS detection
• Presenting data to pre-validation committee for approval to move into validation phase
• Interfacing and/or coordinating with clients, directors, wet lab and scientific staff, project leaders
and project managers on trouble shooting, scientific and technical solutions to enhance efficiency
and communication thus decreasing resources, data processing and generation time and ultimately
increasing cost effectiveness
• Maintaining and calibrating instrumentation and documenting procedures following Quintiles
standard operating procedures (SOP)s
Bristol-Meyers Squibb – East Syracuse, NY
Analytical Chemist, 06/24/2005 to 12/31/2006
Two years validating cGMP-HPLC, PDA, GC methods of currently marketed off patent drugs
manufactured by BMS and its subsidiaries. Responsible for the re-validation of these GMP methods using
as accurate criteria as possible to duplicate validation data sets collected decades before. Validations
performed at request of upper BMS management to resolve questions posed by the FDA of the validity of
current QC testing. Basic duties included:
• Re-validating pharmaceutical compounds manufactured by BMS following cGMP regulations to
comply with updated Bristol SOPs
• Redeveloping methods for assay and/or impurity determination
• Determining potency/purity utilizing HPLC and GC
• Calibrating and maintaining HPLC, PDA, GC/FID systems and documentation
• Generating protocols and final reports for QA approval
• Optimizing validations which required complete re-validation to enhance one or more cGMP
criteria: range, linearity, precision, accuracy, robustness, repeatability, specificity (selectivity),
LLOD, LLOQ, reproducibility and/or impurity detection
Prevalere (formally Oneida Research Services) – Whitesboro, NY
Scientist II, 04/20/1989 to 05/30/2005
Four years developing bioanalytical GLP methods for analyte extraction from biological matrices. Eleven
years validating assays, extraction and sample analysis from biological matrices. Two years conducting
chlorine and fluorine titrations and combustion analysis in chemical analysis division. Basic duties included:
• Developing and optimizing bioanalytical assays utilizing: LC/MS/MS, GC/MS/MS, GC/FID,
GC/ECD, HPLC (UV/VIS, Fluorescence, Photo diode Array)
• Validation of methods
• Sample extraction and instrument analysis under strict adherence to GLP regulations
• Coordinate with internal departments to ease transition of validation into production
• Systems calibration and maintenance
Equipment Experience
Mass Spectrometers
• AB Sciex LC/MS/MS – 6500, 5500 (ion trap and quadrupole function), 5000, 4000, 3000, 300, III
and III Plus (TIS and heated nebulizer for all instruments above)
• Finnigan TSQ and SSQ 4500 and 4600 series mass spectrometers (coupled to Gas
Chromatography)
• Nermag R10-10C single quadrupole mass spectrometer (coupled to Gas Chromatography)
• VG-Trio bench top single quad mass spec (coupled to Gas Chromatography)
Gas Chromatographs
• Hewlett Packard 5890 and 6890
High Performance Liquid Chromatography
• Shimadzu LC-20AD, LC-10ADvp pumps, Shimadzu SCL-10Avp System Contoller
• Waters 600 Solvent Delivery System, Waters Alliance 2690/2695 Pump/Autosampler
Integrated Unit, Waters 2996 Photo-Diode Array, Waters 486 UV/VIS Detector, Waters 470
Scanning Fluorescence Detector
• Perkin-Elmer 200 Pumps/Autoampler
Autoinjection
• LEAP Autoinjectors (injection initiation performed by Analyst, Cycle Composer, or by
LEAP through LEAP controller
Software Experience
Empower (Waters), Analyst 1.6.2 and older versions (Sciex), MacQuan RAD 2.6 and older versions
(Sciex), ExpertEase (Waters), Watson Sample Management System (LIMS system from Thermo),
Cycle Composer (LEAP Technologies),ChemSketch, ChemDraw, MarvinSketch molecular
modeling programs, Microsoft Excel, Word, Power Point
Methodology Experience
Solid Phase Extraction (SPE) Techniques, Liquid/Liquid Extraction (LLE) Techniques, Direct
titration and dilution (cGMP), Dilute/Shoot, Protein Precipitation (solvent protein precip and
protein precipitation plates), some experience with protein binding assays, Cation/Anion exchange
assays and multiple and polar/nonpolar solid phase techniques
Education
PLATTSBURGH STATE UNIVERSITY - Plattsburgh, NY
BA in Environmental Science, 1990
PAUL SMITHS COLLEGE OF ARTS AND SCIENCES – Paul Smiths, NY
AAS, 1986

More Related Content

What's hot

Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...
Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...
Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...
Marcellus Drilling News
 
FDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical Trials
FDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical TrialsFDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical Trials
FDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical Trials
SGS
 
PatResume_update05SEP15
PatResume_update05SEP15PatResume_update05SEP15
PatResume_update05SEP15
pat vilaychack
 
PatResume_update05SEP15
PatResume_update05SEP15PatResume_update05SEP15
PatResume_update05SEP15
pat vilaychack
 
Clia final regulations
Clia final regulationsClia final regulations
Clia final regulations
Moustafa Rezk
 
Analytical method development and validation for simultaneous estimation
Analytical method development and validation for simultaneous estimationAnalytical method development and validation for simultaneous estimation
Analytical method development and validation for simultaneous estimation
Professor Beubenz
 
Analytical Method Development
Analytical Method DevelopmentAnalytical Method Development
Analytical Method Development
Bijesh Verma
 
The Analytical Method Transfer Process SK-Sep 2013
The Analytical Method Transfer Process  SK-Sep 2013The Analytical Method Transfer Process  SK-Sep 2013
The Analytical Method Transfer Process SK-Sep 2013
Stephan O. Krause, PhD
 
Basic skills training guide hplc method development and validation- an over...
Basic skills training guide   hplc method development and validation- an over...Basic skills training guide   hplc method development and validation- an over...
Basic skills training guide hplc method development and validation- an over...
bmarkandeya
 
Ramanaidu CV
Ramanaidu CVRamanaidu CV
Ramanaidu CV
Rma Naidu
 
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...
Stephan O. Krause, PhD
 
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...
Waters Corporation
 
Oil PT Testing Program Paper
Oil PT Testing Program PaperOil PT Testing Program Paper
Oil PT Testing Program Paper
Alvia Gaskill, Jr.
 
Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc
 Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc
Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc
hydrologywebsite1
 
HPLC Method Development & Method Validation (mr.s)
HPLC Method Development & Method Validation (mr.s)HPLC Method Development & Method Validation (mr.s)
HPLC Method Development & Method Validation (mr.s)
22suresh
 
Analytical method transfer (module 01)
Analytical method transfer (module 01)Analytical method transfer (module 01)
Analytical method transfer (module 01)
Dr. Ravi Kinhikar
 
Clinical biochemistry changes
Clinical biochemistry changesClinical biochemistry changes
Clinical biochemistry changes
jdyjdo
 
The paradigm shift – central lab to point of care
The paradigm shift – central lab to point of careThe paradigm shift – central lab to point of care
The paradigm shift – central lab to point of care
jdyjdo
 
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Stephan O. Krause, PhD
 
Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...
PeteDeOlympio
 

What's hot (20)

Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...
Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...
Ohio Dept. of Health Guidelines for Analyzing Samples of Oil & Gas Wastes for...
 
FDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical Trials
FDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical TrialsFDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical Trials
FDA/EMA Inspection - Regulatory Expectations in Early Phase Clinical Trials
 
PatResume_update05SEP15
PatResume_update05SEP15PatResume_update05SEP15
PatResume_update05SEP15
 
PatResume_update05SEP15
PatResume_update05SEP15PatResume_update05SEP15
PatResume_update05SEP15
 
Clia final regulations
Clia final regulationsClia final regulations
Clia final regulations
 
Analytical method development and validation for simultaneous estimation
Analytical method development and validation for simultaneous estimationAnalytical method development and validation for simultaneous estimation
Analytical method development and validation for simultaneous estimation
 
Analytical Method Development
Analytical Method DevelopmentAnalytical Method Development
Analytical Method Development
 
The Analytical Method Transfer Process SK-Sep 2013
The Analytical Method Transfer Process  SK-Sep 2013The Analytical Method Transfer Process  SK-Sep 2013
The Analytical Method Transfer Process SK-Sep 2013
 
Basic skills training guide hplc method development and validation- an over...
Basic skills training guide   hplc method development and validation- an over...Basic skills training guide   hplc method development and validation- an over...
Basic skills training guide hplc method development and validation- an over...
 
Ramanaidu CV
Ramanaidu CVRamanaidu CV
Ramanaidu CV
 
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...
FDA (invited) Presentation - Specifications and Analytical Method Lifecycle f...
 
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...
Using Fusion QbD as an Analytical Quality by Design Software for Method Devel...
 
Oil PT Testing Program Paper
Oil PT Testing Program PaperOil PT Testing Program Paper
Oil PT Testing Program Paper
 
Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc
 Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc
Download-manuals-water quality-technicalpapers-inter-labfindingsaqc3rdround-cwc
 
HPLC Method Development & Method Validation (mr.s)
HPLC Method Development & Method Validation (mr.s)HPLC Method Development & Method Validation (mr.s)
HPLC Method Development & Method Validation (mr.s)
 
Analytical method transfer (module 01)
Analytical method transfer (module 01)Analytical method transfer (module 01)
Analytical method transfer (module 01)
 
Clinical biochemistry changes
Clinical biochemistry changesClinical biochemistry changes
Clinical biochemistry changes
 
The paradigm shift – central lab to point of care
The paradigm shift – central lab to point of careThe paradigm shift – central lab to point of care
The paradigm shift – central lab to point of care
 
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
Risk-based Analytical Method Validation and Maintenance Strategies SK-Sep13
 
Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...Introduction to Analytical Method Development and Validation for Therapeutic ...
Introduction to Analytical Method Development and Validation for Therapeutic ...
 

Viewers also liked

Steak Sales Drive Bigger Checks and Traffic
Steak Sales Drive Bigger Checks and TrafficSteak Sales Drive Bigger Checks and Traffic
Steak Sales Drive Bigger Checks and Traffic
Beeffoodservice
 
Proyecto de-informatica grupo 4
Proyecto de-informatica grupo 4Proyecto de-informatica grupo 4
Proyecto de-informatica grupo 4
Leslye25
 
Constant par diane brébant, charlotte de chillaz
Constant par diane brébant, charlotte de chillazConstant par diane brébant, charlotte de chillaz
Constant par diane brébant, charlotte de chillazTheillier Damien
 
Albury SOTE Powerpoint presentation
Albury SOTE Powerpoint presentationAlbury SOTE Powerpoint presentation
Albury SOTE Powerpoint presentation
Colleen Balfour
 
Powerboat Level 2 - Simon Ager
Powerboat Level 2 - Simon AgerPowerboat Level 2 - Simon Ager
Powerboat Level 2 - Simon AgerSimon Ager
 
Infographic- Dr P Mohamed Ali
Infographic- Dr P Mohamed AliInfographic- Dr P Mohamed Ali
Infographic- Dr P Mohamed Ali
karangandhi11
 
Grupo 3-informática
Grupo 3-informáticaGrupo 3-informática
Grupo 3-informática
Leslye25
 
Techno pedagogy
Techno pedagogyTechno pedagogy
Techno pedagogy
FLORAEUGIN
 
256844466 instalaciones-avicolas
256844466 instalaciones-avicolas256844466 instalaciones-avicolas
256844466 instalaciones-avicolas
Andres Losada
 
Counseling Philosophy
Counseling PhilosophyCounseling Philosophy
Counseling Philosophy
Lisa Andrews
 
Conservation Jean Piaget
Conservation Jean PiagetConservation Jean Piaget
Conservation Jean Piaget
nurulirdina halikulanuar
 
ALGORITMO EPIDEMIOLOGICO CARBUNCO
ALGORITMO EPIDEMIOLOGICO CARBUNCOALGORITMO EPIDEMIOLOGICO CARBUNCO
ALGORITMO EPIDEMIOLOGICO CARBUNCO
ANTONY MOUS
 
2021 Colombia conectada y competitiva
2021 Colombia conectada y competitiva2021 Colombia conectada y competitiva
2021 Colombia conectada y competitiva
PrensaMT
 
Experience of licensees notap presentation
Experience of licensees   notap presentationExperience of licensees   notap presentation
Experience of licensees notap presentation
Rasheed Adegoke
 
Baromètre fidélité 21 mars 2013
Baromètre fidélité 21 mars 2013Baromètre fidélité 21 mars 2013
Baromètre fidélité 21 mars 2013
zefid
 
Dossier très complet sur les vins
Dossier très complet sur les vinsDossier très complet sur les vins
Dossier très complet sur les vins
Denis Papy
 
Степан Фирстов
Степан ФирстовСтепан Фирстов
Степан Фирстов
Asmodeu91
 
Vincent B. Aristote La justice
Vincent B. Aristote La justiceVincent B. Aristote La justice
Vincent B. Aristote La justiceTerminales
 

Viewers also liked (19)

Steak Sales Drive Bigger Checks and Traffic
Steak Sales Drive Bigger Checks and TrafficSteak Sales Drive Bigger Checks and Traffic
Steak Sales Drive Bigger Checks and Traffic
 
Proyecto de-informatica grupo 4
Proyecto de-informatica grupo 4Proyecto de-informatica grupo 4
Proyecto de-informatica grupo 4
 
Constant par diane brébant, charlotte de chillaz
Constant par diane brébant, charlotte de chillazConstant par diane brébant, charlotte de chillaz
Constant par diane brébant, charlotte de chillaz
 
Albury SOTE Powerpoint presentation
Albury SOTE Powerpoint presentationAlbury SOTE Powerpoint presentation
Albury SOTE Powerpoint presentation
 
Reklam
ReklamReklam
Reklam
 
Powerboat Level 2 - Simon Ager
Powerboat Level 2 - Simon AgerPowerboat Level 2 - Simon Ager
Powerboat Level 2 - Simon Ager
 
Infographic- Dr P Mohamed Ali
Infographic- Dr P Mohamed AliInfographic- Dr P Mohamed Ali
Infographic- Dr P Mohamed Ali
 
Grupo 3-informática
Grupo 3-informáticaGrupo 3-informática
Grupo 3-informática
 
Techno pedagogy
Techno pedagogyTechno pedagogy
Techno pedagogy
 
256844466 instalaciones-avicolas
256844466 instalaciones-avicolas256844466 instalaciones-avicolas
256844466 instalaciones-avicolas
 
Counseling Philosophy
Counseling PhilosophyCounseling Philosophy
Counseling Philosophy
 
Conservation Jean Piaget
Conservation Jean PiagetConservation Jean Piaget
Conservation Jean Piaget
 
ALGORITMO EPIDEMIOLOGICO CARBUNCO
ALGORITMO EPIDEMIOLOGICO CARBUNCOALGORITMO EPIDEMIOLOGICO CARBUNCO
ALGORITMO EPIDEMIOLOGICO CARBUNCO
 
2021 Colombia conectada y competitiva
2021 Colombia conectada y competitiva2021 Colombia conectada y competitiva
2021 Colombia conectada y competitiva
 
Experience of licensees notap presentation
Experience of licensees   notap presentationExperience of licensees   notap presentation
Experience of licensees notap presentation
 
Baromètre fidélité 21 mars 2013
Baromètre fidélité 21 mars 2013Baromètre fidélité 21 mars 2013
Baromètre fidélité 21 mars 2013
 
Dossier très complet sur les vins
Dossier très complet sur les vinsDossier très complet sur les vins
Dossier très complet sur les vins
 
Степан Фирстов
Степан ФирстовСтепан Фирстов
Степан Фирстов
 
Vincent B. Aristote La justice
Vincent B. Aristote La justiceVincent B. Aristote La justice
Vincent B. Aristote La justice
 

Similar to Senior Scientist B

GLP in Bioequivalence Studies
GLP in Bioequivalence StudiesGLP in Bioequivalence Studies
GLP in Bioequivalence Studies
Bhaswat Chakraborty
 
Discovery analytical consulting 070617
Discovery analytical consulting 070617Discovery analytical consulting 070617
Discovery analytical consulting 070617
Mark Portsmouth
 
Peter luk
Peter lukPeter luk
Peter luk
Peter Luk
 
JeffWright_Resume_2015
JeffWright_Resume_2015JeffWright_Resume_2015
JeffWright_Resume_2015
Jeffrey Wright
 
Vaccines CMC Analytical Solutions Profile
Vaccines CMC Analytical Solutions Profile Vaccines CMC Analytical Solutions Profile
Vaccines CMC Analytical Solutions Profile
Covance
 
MD-Manager Nichols_Becky 2016
MD-Manager Nichols_Becky 2016MD-Manager Nichols_Becky 2016
MD-Manager Nichols_Becky 2016
Rebecca L. (Becky) Nichols
 
Samha Joshi 2016 resume
Samha Joshi 2016 resumeSamha Joshi 2016 resume
Samha Joshi 2016 resume
Samha Joshi
 
Alessandra braga resume_2016 (alessandra braga)
Alessandra braga resume_2016 (alessandra braga)Alessandra braga resume_2016 (alessandra braga)
Alessandra braga resume_2016 (alessandra braga)
Alessandra Braga
 
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate CapabilitiesDiteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Inc.
 
Bilal Husien Oct-2016
Bilal Husien Oct-2016Bilal Husien Oct-2016
Bilal Husien Oct-2016
Bilal Husien
 
RAJENDRA_CV
RAJENDRA_CVRAJENDRA_CV
RAJENDRA_CV
Rajendra Kolape
 
Quality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.pptQuality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.ppt
SUNILDhatwalia1
 
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Merck Life Sciences
 
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
MilliporeSigma
 
Updated_resume
Updated_resumeUpdated_resume
Updated_resume
Rafael Soto
 
M tyagi resume 2019
M tyagi resume 2019M tyagi resume 2019
M tyagi resume 2019
Manoj Tyagi
 
Research Trends in Different Pharmaceutical Areas .pptx
Research Trends in Different Pharmaceutical Areas .pptxResearch Trends in Different Pharmaceutical Areas .pptx
Research Trends in Different Pharmaceutical Areas .pptx
MdNazmulIslamTanmoy
 
GLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S CharanGLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S Charan
Charan Archakam
 
bio analytical method validation usfda guidlines
bio analytical method validation usfda guidlinesbio analytical method validation usfda guidlines
bio analytical method validation usfda guidlines
chandu chatla
 
A Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method ValidationA Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method Validation
complianceonline123
 

Similar to Senior Scientist B (20)

GLP in Bioequivalence Studies
GLP in Bioequivalence StudiesGLP in Bioequivalence Studies
GLP in Bioequivalence Studies
 
Discovery analytical consulting 070617
Discovery analytical consulting 070617Discovery analytical consulting 070617
Discovery analytical consulting 070617
 
Peter luk
Peter lukPeter luk
Peter luk
 
JeffWright_Resume_2015
JeffWright_Resume_2015JeffWright_Resume_2015
JeffWright_Resume_2015
 
Vaccines CMC Analytical Solutions Profile
Vaccines CMC Analytical Solutions Profile Vaccines CMC Analytical Solutions Profile
Vaccines CMC Analytical Solutions Profile
 
MD-Manager Nichols_Becky 2016
MD-Manager Nichols_Becky 2016MD-Manager Nichols_Becky 2016
MD-Manager Nichols_Becky 2016
 
Samha Joshi 2016 resume
Samha Joshi 2016 resumeSamha Joshi 2016 resume
Samha Joshi 2016 resume
 
Alessandra braga resume_2016 (alessandra braga)
Alessandra braga resume_2016 (alessandra braga)Alessandra braga resume_2016 (alessandra braga)
Alessandra braga resume_2016 (alessandra braga)
 
Diteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate CapabilitiesDiteba Research Laboratories Corporate Capabilities
Diteba Research Laboratories Corporate Capabilities
 
Bilal Husien Oct-2016
Bilal Husien Oct-2016Bilal Husien Oct-2016
Bilal Husien Oct-2016
 
RAJENDRA_CV
RAJENDRA_CVRAJENDRA_CV
RAJENDRA_CV
 
Quality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.pptQuality Assurance Qual Indicators.ppt
Quality Assurance Qual Indicators.ppt
 
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
 
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
Webinar: Is Phase-Appropriate Validation the Right Choice for your Cell or Ge...
 
Updated_resume
Updated_resumeUpdated_resume
Updated_resume
 
M tyagi resume 2019
M tyagi resume 2019M tyagi resume 2019
M tyagi resume 2019
 
Research Trends in Different Pharmaceutical Areas .pptx
Research Trends in Different Pharmaceutical Areas .pptxResearch Trends in Different Pharmaceutical Areas .pptx
Research Trends in Different Pharmaceutical Areas .pptx
 
GLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S CharanGLP in Pharmaceutical Industry by Dr.A S Charan
GLP in Pharmaceutical Industry by Dr.A S Charan
 
bio analytical method validation usfda guidlines
bio analytical method validation usfda guidlinesbio analytical method validation usfda guidlines
bio analytical method validation usfda guidlines
 
A Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method ValidationA Step-by-Step Guide for Method Validation
A Step-by-Step Guide for Method Validation
 

Senior Scientist B

  • 1. Thad Yousey 968 Poplar Ridge Road  Aurora, NY 13026  (315) 525-9251  tyousey@yahoo.com SENIOR DISCOVERY SCIENTIST Experienced Pharmaceutical Research and Assay Development Over twelve years of experience thoroughly researching, developing, validating and documenting assays for GLP pharmacokinetic and pharmacodynamic clinical studies focusing on precision, accuracy, high throughput and streamlined assay reproducibility of Phase 0-4 analytes of interest. Developing and validating assays for preclinical experimental compounds and pro drugs. Developing and generating methods, validations and all documentation in support of cGMP methods with strict adherence to FDA and ICH guidelines. Performing validation confirmations of cGMP assays to support production line quality control methods. Experience QUINTILES -- Ithaca, NY Senior Discovery Scientist, 07/11/2007 to 04/19/2015 Eight years developing bioanalytical GLP and non GLP methods for analyte extraction from biological matrices utilizing LC/MS/MS detection. These methods were ultimately used for the generation of pharmacokinetic data by some of the world’s largest pharmaceutical providers to support; data in client drug discovery, maximizing accuracy of Cmax and AUC values for future clinical study drug delivery, substantiate NDA submissions and/or provide data sets for currently marketed compounds (FDA requirements). Basic duties included: • Structural confirmations of analytes, precursors, adducts (if present), ion polarity(ies) functionality and product ions - utilizing LC/MS/MS (turbo ion spray and heated nebulizer) • Developing and optimizing mass spectrometric methods and parameters in tandem with HPLC • Developing and optimizing HPLC methods (reversed, normal phase, HLIC, ion pairing) and parameters assessing; resolution, capacity factor, peak selectivity, highest throughput, API and or APCI compatibility and client timeline/demands • Developing/validating chiral and isomeric selective HPLC assays including confirmation of all chromatographically resolved species • Researching, developing and validating methods of extraction for analytes, metabolites internal standards (analogue and stable labeled) and/or pro-drugs from biological matrices to be utilized in LC/MS/MS detection • Presenting data to pre-validation committee for approval to move into validation phase • Interfacing and/or coordinating with clients, directors, wet lab and scientific staff, project leaders and project managers on trouble shooting, scientific and technical solutions to enhance efficiency and communication thus decreasing resources, data processing and generation time and ultimately increasing cost effectiveness • Maintaining and calibrating instrumentation and documenting procedures following Quintiles standard operating procedures (SOP)s
  • 2. Bristol-Meyers Squibb – East Syracuse, NY Analytical Chemist, 06/24/2005 to 12/31/2006 Two years validating cGMP-HPLC, PDA, GC methods of currently marketed off patent drugs manufactured by BMS and its subsidiaries. Responsible for the re-validation of these GMP methods using as accurate criteria as possible to duplicate validation data sets collected decades before. Validations performed at request of upper BMS management to resolve questions posed by the FDA of the validity of current QC testing. Basic duties included: • Re-validating pharmaceutical compounds manufactured by BMS following cGMP regulations to comply with updated Bristol SOPs • Redeveloping methods for assay and/or impurity determination • Determining potency/purity utilizing HPLC and GC • Calibrating and maintaining HPLC, PDA, GC/FID systems and documentation • Generating protocols and final reports for QA approval • Optimizing validations which required complete re-validation to enhance one or more cGMP criteria: range, linearity, precision, accuracy, robustness, repeatability, specificity (selectivity), LLOD, LLOQ, reproducibility and/or impurity detection Prevalere (formally Oneida Research Services) – Whitesboro, NY Scientist II, 04/20/1989 to 05/30/2005 Four years developing bioanalytical GLP methods for analyte extraction from biological matrices. Eleven years validating assays, extraction and sample analysis from biological matrices. Two years conducting chlorine and fluorine titrations and combustion analysis in chemical analysis division. Basic duties included: • Developing and optimizing bioanalytical assays utilizing: LC/MS/MS, GC/MS/MS, GC/FID, GC/ECD, HPLC (UV/VIS, Fluorescence, Photo diode Array) • Validation of methods • Sample extraction and instrument analysis under strict adherence to GLP regulations • Coordinate with internal departments to ease transition of validation into production • Systems calibration and maintenance Equipment Experience Mass Spectrometers • AB Sciex LC/MS/MS – 6500, 5500 (ion trap and quadrupole function), 5000, 4000, 3000, 300, III and III Plus (TIS and heated nebulizer for all instruments above) • Finnigan TSQ and SSQ 4500 and 4600 series mass spectrometers (coupled to Gas Chromatography) • Nermag R10-10C single quadrupole mass spectrometer (coupled to Gas Chromatography) • VG-Trio bench top single quad mass spec (coupled to Gas Chromatography) Gas Chromatographs • Hewlett Packard 5890 and 6890 High Performance Liquid Chromatography • Shimadzu LC-20AD, LC-10ADvp pumps, Shimadzu SCL-10Avp System Contoller • Waters 600 Solvent Delivery System, Waters Alliance 2690/2695 Pump/Autosampler Integrated Unit, Waters 2996 Photo-Diode Array, Waters 486 UV/VIS Detector, Waters 470
  • 3. Scanning Fluorescence Detector • Perkin-Elmer 200 Pumps/Autoampler Autoinjection • LEAP Autoinjectors (injection initiation performed by Analyst, Cycle Composer, or by LEAP through LEAP controller Software Experience Empower (Waters), Analyst 1.6.2 and older versions (Sciex), MacQuan RAD 2.6 and older versions (Sciex), ExpertEase (Waters), Watson Sample Management System (LIMS system from Thermo), Cycle Composer (LEAP Technologies),ChemSketch, ChemDraw, MarvinSketch molecular modeling programs, Microsoft Excel, Word, Power Point Methodology Experience Solid Phase Extraction (SPE) Techniques, Liquid/Liquid Extraction (LLE) Techniques, Direct titration and dilution (cGMP), Dilute/Shoot, Protein Precipitation (solvent protein precip and protein precipitation plates), some experience with protein binding assays, Cation/Anion exchange assays and multiple and polar/nonpolar solid phase techniques Education PLATTSBURGH STATE UNIVERSITY - Plattsburgh, NY BA in Environmental Science, 1990 PAUL SMITHS COLLEGE OF ARTS AND SCIENCES – Paul Smiths, NY AAS, 1986